Giampiero Romano

427 total citations
21 papers, 307 citations indexed

About

Giampiero Romano is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Giampiero Romano has authored 21 papers receiving a total of 307 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 10 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Giampiero Romano's work include Cancer Immunotherapy and Biomarkers (6 papers), Lung Cancer Treatments and Mutations (5 papers) and Immunotherapy and Immune Responses (3 papers). Giampiero Romano is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Lung Cancer Treatments and Mutations (5 papers) and Immunotherapy and Immune Responses (3 papers). Giampiero Romano collaborates with scholars based in Italy, United States and Poland. Giampiero Romano's co-authors include Alfredo Tartarone, Mario Falsaperla, Giuseppe Morgia, Raffaele Ardito, Valeria Covacci, Alma Boninsegna, Achille Cittadini, Alessandro Sgambato, Federica I. Wolf and Angela Torsello and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

In The Last Decade

Giampiero Romano

20 papers receiving 291 citations

Peers

Giampiero Romano
Stephanie Soares United States
Jin Su China
L. Fioravanti Italy
Anna Zasowska‐Nowak Poland
Tinuccia Dettori Italy
Molly M. Hood United States
Claudine Kavanaugh United States
Hayato Urushima Japan
Léon T. van den Broeke Netherlands
Donghu Zhou China
Stephanie Soares United States
Giampiero Romano
Citations per year, relative to Giampiero Romano Giampiero Romano (= 1×) peers Stephanie Soares

Countries citing papers authored by Giampiero Romano

Since Specialization
Citations

This map shows the geographic impact of Giampiero Romano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giampiero Romano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giampiero Romano more than expected).

Fields of papers citing papers by Giampiero Romano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giampiero Romano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giampiero Romano. The network helps show where Giampiero Romano may publish in the future.

Co-authorship network of co-authors of Giampiero Romano

This figure shows the co-authorship network connecting the top 25 collaborators of Giampiero Romano. A scholar is included among the top collaborators of Giampiero Romano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giampiero Romano. Giampiero Romano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Besse, Benjamin, M.R. García Campelo, Élisabeth Quoix, et al.. (2021). LBA47 Activity of OSE-2101 in HLA-A2+ non-small cell lung cancer (NSCLC) patients after failure to immune checkpoint inhibitors (IO): Final results of phase III Atalante-1 randomised trial. Annals of Oncology. 32. S1325–S1325. 11 indexed citations
3.
Ragusa, Andrea, Marcello Salvatore Lenucci, Daniele Vergara, et al.. (2021). Differential Glycosylation Levels in Saliva from Patients with Lung or Breast Cancer: A Preliminary Assessment for Early Diagnostic Purposes. Metabolites. 11(9). 566–566. 15 indexed citations
4.
5.
Felip, Enriqueta, Giuseppe Giaccone, Rafał Dziadziuszko, et al.. (2019). ATALANTE-1 randomized phase III trial, OSE 2101 versus standard treatment as second- or third-line in HLA-A2 positive advanced non-small cell lung cancer (NSCLC) patients.. Journal of Clinical Oncology. 37(15_suppl). TPS9121–TPS9121. 2 indexed citations
6.
Marinis, Filippo de, Massimo Barberis, Vito Barbieri, et al.. (2019). Diagnosis and first-line treatment of non-small cell lung cancer in the era of novel immunotherapy: recommendations for clinical practice. Expert Review of Respiratory Medicine. 13(3). 217–228. 10 indexed citations
7.
Capelletto, Enrica, Alessandro Morabito, Francesco Grossi, et al.. (2019). Post progression survival for patients treated with docetaxel/nintedanib in the SENECA trial. Annals of Oncology. 30. v645–v646. 1 indexed citations
8.
Besse, Benjamin, Sylvestre Le Moulec, Julien Mazières, et al.. (2017). P2.06-024 Tedopi vs Standard Treatment as 2nd or 3rd Line in HLA-A2 Positive Advanced NSCLC Patients in a Phase 3, Randomized Trial: ATALANTE-1. Journal of Thoracic Oncology. 12(1). S1085–S1086. 1 indexed citations
9.
Migliorino, Maria Rita, Antonio Santo, Giampiero Romano, et al.. (2017). Economic burden of patients affected by non-small cell lung cancer (NSCLC): the LIFE study. Journal of Cancer Research and Clinical Oncology. 143(5). 783–791. 36 indexed citations
10.
Lorusso, Vito, et al.. (2008). Vinorelbine plus capecitabine in salvage therapy of breast cancer. Comparison of intravenous vs oral administration of vinorelbine. Journal of Clinical Oncology. 26(15_suppl). 1114–1114. 4 indexed citations
11.
Lorusso, Vito, et al.. (2007). Phase II study of capecitabine in combination with cisplatin in advanced head and neck cancer: Preliminary results. Journal of Clinical Oncology. 25(18_suppl). 16502–16502. 1 indexed citations
12.
Tartarone, Alfredo, Giuseppina Gallucci, Giovanni Iodice, et al.. (2004). Linezolid-induced bradycardia: a case report. International Journal of Antimicrobial Agents. 23(4). 412–413. 8 indexed citations
13.
Falsaperla, Mario, Giuseppe Morgia, Alfredo Tartarone, Raffaele Ardito, & Giampiero Romano. (2004). Support Ellagic Acid Therapy in Patients with Hormone Refractory Prostate Cancer (HRPC) on Standard Chemotherapy Using Vinorelbine and Estramustine Phosphate. European Urology. 47(4). 449–455. 96 indexed citations
14.
Mele, Giuseppe, Rosella Matera, Maria Luigia Vigliotti, et al.. (2004). High-Dose of Epoietin Alfa in Patients with Low-Risk Myelodysplastic Syndromes (MDS): A Single Institution Experience.. Blood. 104(11). 4703–4703. 4 indexed citations
15.
Tartarone, Alfredo, et al.. (2002). Pulmonary Blastoma after Liver Transplant: A Case Report. Tumori Journal. 88(2). 173–175. 2 indexed citations
16.
Covacci, Valeria, Angela Torsello, Paola Palozza, et al.. (2001). DNA Oxidative Damage during Differentiation of HL-60 Human Promyelocytic Leukemia Cells. Chemical Research in Toxicology. 14(11). 1492–1497. 53 indexed citations
17.
Facchini, Gaetano, Michele Santangelo, Iacopo Carbone, et al.. (1997). Abdominal and pelvic stop-flow (hypoxic, chemotherapeutic loco-regional treatment): Preliminary report of a phase I study. European Journal of Cancer. 33. S252–S252. 2 indexed citations
18.
Mussoni, L., Giuseppe Pintucci, Giampiero Romano, et al.. (1990). Decreased fibrinolytic activity in juvenile chronic arthritis.. Annals of the Rheumatic Diseases. 49(12). 973–975. 4 indexed citations
19.
Bertelè, Vittorio, L. Mussoni, Giuseppe Pintucci, et al.. (1989). The Inhibitory Effect of Aspirin on Fibrinolysis Is Reversed by Iloprost, a Prostacyclin Analogue. Thrombosis and Haemostasis. 61(2). 286–288. 15 indexed citations
20.
Temponi, M, et al.. (1988). Profile of intercellular adhesion molecule-1 (ICAM-1) synthesized by human melanoma cell lines.. PubMed. 15(6). 595–607. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stephanie Soares Breakdown of academic impact, for papers by Jin Su Breakdown of academic impact, for papers by L. Fioravanti Breakdown of academic impact, for papers by Anna Zasowska‐Nowak Breakdown of academic impact, for papers by Tinuccia Dettori Breakdown of academic impact, for papers by Molly M. Hood Breakdown of academic impact, for papers by Claudine Kavanaugh Breakdown of academic impact, for papers by Hayato Urushima Breakdown of academic impact, for papers by Léon T. van den Broeke Breakdown of academic impact, for papers by Donghu Zhou
Rankless by CCL
2026